Metohexal

Metoprolol succinate, the active ingredient in Metohexal, is a beta blocker presented as an oral tablet for oral use. It lowers blood pressure, reduces myocardial oxygen demand, and is employed in the management of hypertension, angina, and heart failure in adult patients. GNH USA supplies Metohexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metohexal, a selective β1‑adrenergic blocker, is used in several cardiovascular conditions. - Hypertension: lowers elevated arterial pressure and reduces cardiovascular risk. - Angina pectoris: decreases myocardial oxygen consumption, relieving chest pain. - Chronic heart failure: improves ventricular function and reduces hospitalizations. - Post‑myocardial infarction prophylaxis: lowers the chance of recurrent cardiac events.

Metohexal may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities - Gastrointestinal upset (nausea, abdominal discomfort) - Headache

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma - Allergic reactions (rash, angioedema) - Depression or mood changes - Worsening heart failure symptoms

Before initiating Metohexal, several safety considerations should be observed. - Monitor blood pressure: ensure adequate control and avoid hypotension. - Assess heart rate: watch for excessive bradycardia. - Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension or tachycardia. - Adjust dose in renal impairment: consider reduced clearance. - Store at room temperature: keep in the original container, protect from moisture.

Metohexal can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Non‑selective beta‑blockers (e.g., propranolol) – additive cardiac depression. - Calcium channel blockers verapamil or diltiazem – risk of severe bradycardia. - Clonidine – may cause hypertensive crisis if stopped abruptly. - Insulin or oral hypoglycemics – mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely): - Diuretics – may enhance hypotensive effect. - ACE inhibitors or ARBs – monitor for additive blood pressure lowering. - NSAIDs – may reduce antihypertensive efficacy. - Certain antidepressants (SSRIs) – watch for heart rate changes.